https://www.aph.gov.au/Parliamentary_Business/Hansard/Hansard_Display?bid=chamber/hansardr/1e631be5-f3d6-413c-aead-186f98561fb6/&sid=0152
Chamber - House of Representativeson 22/06/2021
Item - BILLS - COVID-19 Disaster Payment (Funding Arrangements) Bill 2021 - Second Reading
Speaker - Kelly, Craig, MP
Mr CRAIG KELLY (Hughes) (18:34): To start my contribution on the COVID-19 Disaster Payment (Funding Arrangements) Bill 2021, I'd like to pick up from where the member for Dunkley left off about the changing health advice. It is correct that the health advice on the vaccination program has changed. But what that actually shows is how mistaken it would have been to follow the advice of members of the opposition who wanted to rush out the vaccine in the earlier days. Their call was that we must get more injections into the arms of people. But, because of that rushing out, we now have in this country 800,000 Australians who have been injected with a substance which our Chief Medical Officer now says poses greater risks to them than any potential benefit that they have received. That is historic proportions—that 800,000 Australians would be subject to a medical treatment where the Chief Medical Officer of the country now acknowledges that the risk to those people was greater than the benefits they received. And we know that dozens of those people have suffered from blood clots. This is the mistake that can happen when we panic and we rush, which was exactly the call that we heard from members of the opposition.
When it comes to working out our steps and procedure in tackling COVID, surely we must look at all the evidence. The first place that we might look to is a group called the National COVID-19 Clinical Evidence Taskforce. I have been critical of this task force in the past. However, it is interesting to note their latest findings on ivermectin. I know that members of the opposition have called ivermectin snake oil and they have said that it doesn't work. Well, let's have a look at what the National COVID-19 Clinical Evidence Taskforce says about this. They say: 'Evidence comes from 13 randomised trials in over 1,260 adults.' So they're actually getting up there in the number of randomised trials and the number of adults. What does our national evidence task force find? Surprise, surprise, they found a 67 per cent reduction in death in those who were administered ivermectin who caught COVID as compared to those that weren't—a 67 per cent reduction in death. They've also found a 46 per cent reduction in ICU admissions. That's what they found. Yet, despite those amazing figures, which show an almost 50 per cent decline in ICU admissions and a 67 per cent decline in death, our national clinical evidence task force somehow still recommends against ivermectin.
There is evidence that's now on the table, including the international peer reviewed evidence published only a few days ago in the American Journal of Therapeutics—a Cochrane standard, peer-reviewed meta-analysis, for the education of the members sitting over to my right—by researchers over in the UK. We've heard that apparently some of these studies that are not done in the UK should be discounted, but this is actually a peer-reviewed meta-analysis from the United Kingdom by Bryant and Lawrie. What did they find on ivermectin? I'll quote directly. They said that 'meta-analysis of 15 trials found that ivermectin reduced risk of death compared with no ivermectin' by 62 per cent in their study of 2,438 patients. They also found that 'ivermectin prophylaxis reduced COVID-19 infections by an average of 86 per cent'.
I put it to you, Deputy Speaker, that it is now game over for the ivermectin deniers with this peer-reviewed meta-analysis study. All those on the other side who continue to deny ivermectin are putting Australian lives at risk. The evidence is clear. The evidence is here. These people love to say, 'We must have peer-reviewed studies.' Well, here it is: a peer reviewed meta-analysis of 15 studies showing a 62 per cent reduction in the risk of death and an incredible 86 per cent reduction of COVID infections when used as a prophylaxis. Let me read the final conclusion of this meta-analysis, peer-reviewed published study:
Given the evidence of efficacy, safety, low cost and current death rates, ivermectin is likely to have an impact on health and economic outcomes of the pandemic across many countries. Ivermectin is not a new and experimental drug with an unknown safety profile. It is a WHO 'Essential Medicine' already used in several different indications, in colossal cumulative volumes.
And those volumes are in the billions of doses. It continues:
Corticosteroids have become an accepted standard of care in covid-19, based on a single RCT of dexamethasone 1. If a single RCT is sufficient for the adoption of dexamethasone, then … two dozen RCTs supports the adoption of Ivermectin...
Go to the link above to see the rest of Mr
